ClearSkin
Microbiomic Treatment for Psoriasis and Other Skin Conditions
Startup Pre-Funding Health Tech & Life Sciences Est. 2017
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
2
1-10 employees
Confidence
90/100
Patents
1
About
ClearSkin Medical specializes in innovative treatments for skin diseases. The company has developed and launched MiBiome, a first-generation product focused on the dermal microbiome to treat psoriasis, atopic dermatitis, eczema, urticaria, itching, and other skin conditions. MiBiome is an innovative all natural product formulated with a probiotic complex to soothe and rebalance the ecosystem of the skin.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue Engineering
Core Technology
BiologicalsMicroorganisms
Target Customer
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticalsBiotechnology
Business Model
B2CB2B
Tags
skin-caredermatologychronic-patientspharmaceuticalstreatmentspatientspharma-companies
Details
Product Stage
Released
Employees
1-10
Exact Count
3
District
North District
Founded
2017
Registrar
515772127
Locations
Hen Street 28, Karmiel, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Apr 26, 2023
Verified by
Jenny Sotnik-Talisman
Missing
video or image, funding rounds, news, markets, not claimed
Team (2)
Milana Shternberg
CEO & Founder
Founder
Veronika Loiferman
COO & Co-Founder
Founder
Internal
Created by
Yanina Wainscheinker (yanina.wain@gmail.com)
Created
2018-01-29T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)